October 01, 2020
The global market for smart inhalers was valued at $104.7 million in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 26.8% to reach approximately $512.1 million by 2024, Smart Inhalers: Global Markets.
For more than 50 years, inhalers have had a poor track record in terms of patient adherence. With around 500 million people worldwide suffering from asthma and COPD, any treatment improvements are welcome indeed.
“Smart” inhalers, those with added digital features which communicate with an app on a patient’s mobile device, are poised for wide acceptance and regulatory approval, and pharma companies are racing to partner with software platforms to take advantage.
Inhalers that remind you when it’s time to take a dose, warn you of poor air quality (pollen, smoke, etc.), and correct poor technique, are about to change the market drastically. Additionally, these devices will make it easier for clinicians to monitor and verify patient’s adherence, allowing a clarity of information leading to more effective care decisions.
Read the full report here: https://www.bccresearch.com/market-research/medical-devices-and-surgical/smart-inhalers-market.html
Smart Inhalers: Global Markets( MDS021A )
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email firstname.lastname@example.org or visit www.bccresearch.com/media to request access to our library of market research.